<DOC>
	<DOC>NCT00108771</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness of the Matrix Fentanyl Patch ZR-02-01 in providing pain relief.</brief_summary>
	<brief_title>Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain</brief_title>
	<detailed_description>This study will evaluate the analgesic efficacy of the matrix fentanyl patch. The study will be conducted in non-opioid tolerant patients with moderate to severe osteoarthritis (OA) pain. This patient population was chosen in anticipation that the patients are otherwise healthy adults being treated with NSAIDs (Nonsteroidal Anti-inflammatory Drugs) or acetaminophen or who have received intermittent opioid analgesic treatment.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Adults between the ages of 40 and 75 years of age suffering from moderate to severe chronic pain caused by osteoarthritis. Patient is already taking chronic opioids or has a history of substance abuse or has a substance abuse disorder.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Pain</keyword>
	<keyword>Chronic Pain</keyword>
	<keyword>Osteoarthritis Pain</keyword>
	<keyword>Osteoarthritis</keyword>
</DOC>